Calendar Transcenta Holding Limited

Equities

6628

KYG9005B1041

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
1.78 HKD +1.71% Intraday chart for Transcenta Holding Limited +5.95% -50.42%

Chart calendar Transcenta Holding Limited

463544ccfa4a221ea42518e.dn9LtzPkmvClVP40Mr8_0AZygp0eWG__bWU2L00f-aU.BjAb1nLc6ZqSPoZgfc9NgHBD7ctVHirGCyhkehlWlZVEOj3vUKvNnJ0utw~eae78e31012dc7da056ffda873200725

Upcoming events on Transcenta Holding Limited

2024-08-25 Q2 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)
2025-08-31 Q2 2025 Earnings Release (Projected)
2026-03-25 Q4 2025 Earnings Release (Projected)

Past events on Transcenta Holding Limited

2024-03-27 Q4 2023 Earnings Call
2024-03-26 Q4 2023 Earnings Release
2024-03-24 10:00 pm Extraordinary Shareholders Meeting
2023-10-19 European Society for Medical Oncology Congress - Abstract#: 1570P
2023-10-19 European Society for Medical Oncology Congress - Abstract#: 1556P
2023-10-19 European Society for Medical Oncology Congress - Abstract#: 4038
2023-08-21 Q2 2023 Earnings Release
2023-06-08 10:00 pm Annual General Meeting
2023-06-07 08:00 am Business Update Call
2023-06-05 09:00 am American Society of Clinical Oncology Conference - Abstract#: TPS4176
2023-06-05 08:00 am American Society of Clinical Oncology Conference - Abstract#: 4046
2023-04-17 09:00 am American Association for Cancer Research Meeting - Abstract #1546
2023-04-16 01:30 pm American Association for Cancer Research Meeting - Abstract #465
2023-03-30 10:00 pm Q4 2022 Earnings Call
2023-03-29 Q4 2022 Earnings Release
2023-01-19 03:00 pm American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number: TPS476
2022-11-14 Goldman Sachs Asia Pacific Healthcare Forum
2022-11-10 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract#: 105
2022-11-10 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract#: 771
2022-11-09 09:30 am TEMTIA Meeting

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million CNY
Released
Forecast
Spread
50,2
50,0
0.48%
102
72,7
40.17%
53,8
121
-55.55%

161

EBITDA
Million CNY
Released
Forecast
Spread
-434
-463
6.11%
-399
-551
27.68%
-442
-561
21.26%

-279

EBIT
Million CNY
Released
Forecast
Spread
-480
-526
8.62%
-442
-600
26.22%
-485
-628
22.77%

-324

Earnings before Tax (EBT)
Million CNY
Released
Forecast
Spread
0,00
0,00
-
-407
-650
37.39%
-463
-621
25.43%

-309

Net income
Million CNY
Released
Forecast
Spread
0,00
0,00
-
-407
-650
37.42%
-463
-621
25.47%

-309

EPS
CNY
Released
Forecast
Spread
0,00
0,00
-
-0,94
-1,46
35.62%
-1,14
-1,45
21.38%

-0,76

Announcement Date21/03/2230/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million CNY
Released
Forecast
Spread
23,6
23,3
1.04%



80,1
26,0
208.54%
36,1
55,0
-34.42%
17,8
86,2
-79.39%

26,7


135

EBIT
Million CNY
Released
Forecast
Spread
-276
-321
14.12%



-216
-339
36.22%
-256
-214
-19.27%
-229
-244
6.19%

-197


-127

Net income
Million CNY
Released
Forecast
Spread



-204

















EPS
CNY
Released
Forecast
Spread



-0,47





-0,58
-0,46
-26.09%
-0,56
-0,51
-9.8%

-0,46


-0,29

Announcement Date21/03/2229/08/2230/03/2322/08/2327/03/24--

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6628 Stock
  4. Calendar Transcenta Holding Limited